Abstract
This commentary is on the original article by Hausman–Kedem et al. on pages 1348–1360 of this issue.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflicts of interest.
DATA AVAILABILITY STATEMENT
Not required.
REFERENCES
- 1Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996; 132: 307–11.
- 2Siegel DH, Tefft KA, Kelly T, Johnson C, Metry D, Burrows P, et al. Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE) syndrome: a systematic review of the literature. Stroke. 2012; 43: 1672–4.
- 3Garzon MC, Epstein LG, Heyer GL, Frommelt PC, Orbach DB, Baylis AL, et al. PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations. J Pediatr. 2016; 178: 24–33.
- 4Braun M, Frieden IJ, Siegel DH, George E, Hess CP, Fox CK, et al. Multicenter Study of Long-term Outcomes and Quality of Life in PHACE Syndrome after Age 10. J Pediatr. 2024: 113907.
- 5Wiśniewski K, Tyfa Z, Reorowicz P, Brandel MG, Adel T, Obidowski D, et al. Numerical flow experiment for assessing predictors for cerebrovascular accidents in patients with PHACES syndrome. Sci Rep. 2024; 14: 5161.
- 6Hausman-Kedem M, Widjaja E, Viera Neto RJ, Pope E, Lara-Corrales I, Dlamini N, et al. Long-term clinical and radiological trajectories of craniocervical vasculopathy in children with PHACE syndrome. Dev Med Child Neurol. 2024 Apr 10. https://doi.org/10.1111/dmcn.15916. Online ahead of print.
